On Tuesday, Aspen hosted South African President Cyril Ramaphosa at its sterile facility, where the company will be manufacturing the Johnson & Johnson Covid-19 vaccine. Johnson & Johnson has agreed to supply 250 million vaccines for Africa, with 30 million being for South Africa. Stephen Saad, CEO at Aspen joins CNBC Africa for more.
SA should focus heavily on vaccine rollout, says Aspen CEO Stephen Saad
PUBLISHED: Wed, 31 Mar 2021 13:13:52 GMT
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.
Tv
